Decades of randomized controlled trials establish its efficacy for photoaging, fine lines, and pigmentation in a way that GHK-Cu cannot yet match
Unlike treatment with GLP-1RAs, which generally leads to body weight and fat mass reduction, pioglitazone dose-dependently increases body weight and fat mass
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
Thymosin alpha-1 enhances immune function, benefitting individuals dealing with chronic infections, autoimmune disorders, or immune suppression
, ,
Bariatric surgery offers a more permanent solution by addressing the root causes of obesity, unlike GLP-1 receptor agonists, which often require long-term use and come with potential side effects such as gastrointestinal symptoms, thyroid tumors, and kidney injury